Norma Sue Kenyon
Vice Provost for Innovation
University of Miami
Norma Sue Kenyon, Ph.D. is Vice Provost for Innovation at the University of Miami and Chief Innovation Officer of the Miller School of Medicine. Under her leadership, the U Innovation team, including the Office of Technology Transfer and the Wallace H. Coulter Center for Translational Research, has succesfully increased the number of licensing agreements and startups from across the university’s 11 schools and colleges. Kenyon also leads a master planning process to develop an innovation district around UM’s life science park (now known as Converge Miami), and as part of the university’s roadmap initiative, is heading up planning for innovation across the university.
A Professor of Surgery, Microbiology & Immunology and Biomedical Engineering at the Diabetes Research Institute, Dr. Kenyon and her research team have focused on ways to transplant insulin producing islet cells, in both clinically relevant transplant models and in clinical studies, without the need for life-long anti-rejection drugs. Key accomplishments in both clinically relevant transplant models and clinical studies include development and sharing of methods for islet and islet/bone marrow transplantation, demonstration of insulin independence and long-term islet survival and incorporation of stem cells to enhance islet engraftment and survival. Kenyon has received research funding from the National Institute of Allergy and Infectious Disease, the National Institute of Diabetes, Digestive and Kidney Diseases, the Juvenile Diabetes Research Foundation International, the Diabetes Research Institute Foundation and several industry collaborators. She has served as Chair for Immunology in the NIH funded Type 1 Diabetes TrialNet and the Clinical Islet Transplant consortiums. Kenyon has also served as a member of the National Advisory Allergy and Infectious Disease Council and recently finished service as a member of the NIH Council of Councils. Kenyon was a scientific advisor to the Food and Drug Administration, spending half her time at the FDA for a year and has participated in several panels involving islet transplantation.
Kenyon earned her undergraduate degree from Duke University and her Ph.D. from Virginia Commonwealth University, followed by post-doctoral positions at UCLA and the University of Miami. Subsequent to post-doctoral training, Kenyon was a Senior Scientist and Lab Head at Coulter Corporation, holding positions in both research and product development.